Mesenchymal stem cells in the treatment of diabetes mellitus: perspectives
Over recent decades, diabetes mellitus remains one of the main public healthcare problems worldwide with a tendency to steady growth. Actual prevalence of only type 2 diabetes mellitus among adults (20-79 years old) in Kazakhstan was higher than it was expected and amounted to 8.2% according to the...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
National Scientific Medical Research Center
2018-09-01
|
Series: | Ķazaķstannyṇ Klinikalyķ Medicinasy |
Subjects: | |
Online Access: | https://www.clinmedkaz.org/download/mesenchymal-stem-cells-in-the-treatment-of-diabetes-mellitus-perspectives-9026.pdf |
id |
doaj-02adfc9e7d944b01a8923f7364c0a3a5 |
---|---|
record_format |
Article |
spelling |
doaj-02adfc9e7d944b01a8923f7364c0a3a52021-02-04T19:57:25ZengNational Scientific Medical Research CenterĶazaķstannyṇ Klinikalyķ Medicinasy1812-28922313-15192018-09-01349323410.23950/1812-2892-JCMK-00591Mesenchymal stem cells in the treatment of diabetes mellitus: perspectivesOlga Ulyanova0Temirlan Karibekov1Galiya Shaimardanova2Larissa Kozina3Endocrine Disturbances Department, National Scientific Medical Center, Astana, Republic of KazakhstanScientific Research Management Department, National Scientific Medical Center, Astana, Republic of KazakhstanScientific Research Management Department, National Scientific Medical Center, Astana, Republic of KazakhstanClinical and Diagnostic Laboratory, National Scientific Medical Center, Astana, Republic of KazakhstanOver recent decades, diabetes mellitus remains one of the main public healthcare problems worldwide with a tendency to steady growth. Actual prevalence of only type 2 diabetes mellitus among adults (20-79 years old) in Kazakhstan was higher than it was expected and amounted to 8.2% according to the Kazakh epidemiological study NOMAD. Diabetes mellitus is a major risk factor for ischemic heart disease and stroke, which collectively account for high rates of morbidity and mortality among adult patients. Transplantation of mesenchymal stem cells was considered to be the most promising treatment approach for diabetes mellitus.https://www.clinmedkaz.org/download/mesenchymal-stem-cells-in-the-treatment-of-diabetes-mellitus-perspectives-9026.pdfc-peptideadipokinespancreatic islet cell regeneration |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Olga Ulyanova Temirlan Karibekov Galiya Shaimardanova Larissa Kozina |
spellingShingle |
Olga Ulyanova Temirlan Karibekov Galiya Shaimardanova Larissa Kozina Mesenchymal stem cells in the treatment of diabetes mellitus: perspectives Ķazaķstannyṇ Klinikalyķ Medicinasy c-peptide adipokines pancreatic islet cell regeneration |
author_facet |
Olga Ulyanova Temirlan Karibekov Galiya Shaimardanova Larissa Kozina |
author_sort |
Olga Ulyanova |
title |
Mesenchymal stem cells in the treatment of diabetes mellitus: perspectives |
title_short |
Mesenchymal stem cells in the treatment of diabetes mellitus: perspectives |
title_full |
Mesenchymal stem cells in the treatment of diabetes mellitus: perspectives |
title_fullStr |
Mesenchymal stem cells in the treatment of diabetes mellitus: perspectives |
title_full_unstemmed |
Mesenchymal stem cells in the treatment of diabetes mellitus: perspectives |
title_sort |
mesenchymal stem cells in the treatment of diabetes mellitus: perspectives |
publisher |
National Scientific Medical Research Center |
series |
Ķazaķstannyṇ Klinikalyķ Medicinasy |
issn |
1812-2892 2313-1519 |
publishDate |
2018-09-01 |
description |
Over recent decades, diabetes mellitus remains one of the main public healthcare problems worldwide with a tendency to steady growth. Actual prevalence of only type 2 diabetes mellitus among adults (20-79 years old) in Kazakhstan was higher than it was expected and amounted to 8.2% according to the Kazakh epidemiological study NOMAD. Diabetes mellitus is a major risk factor for ischemic heart disease and stroke, which collectively account for high rates of morbidity and mortality among adult patients. Transplantation of mesenchymal stem cells was considered to be the most promising treatment approach for diabetes mellitus. |
topic |
c-peptide adipokines pancreatic islet cell regeneration |
url |
https://www.clinmedkaz.org/download/mesenchymal-stem-cells-in-the-treatment-of-diabetes-mellitus-perspectives-9026.pdf |
work_keys_str_mv |
AT olgaulyanova mesenchymalstemcellsinthetreatmentofdiabetesmellitusperspectives AT temirlankaribekov mesenchymalstemcellsinthetreatmentofdiabetesmellitusperspectives AT galiyashaimardanova mesenchymalstemcellsinthetreatmentofdiabetesmellitusperspectives AT larissakozina mesenchymalstemcellsinthetreatmentofdiabetesmellitusperspectives |
_version_ |
1724284670873436160 |